COVID-19 is a serious health concern and the impact on our lives continues to evolve on a daily basis. In these unprecedented times, individuals with pre-existing conditions need to be especially careful. With the distribution of the Pfizer-BioNTech COVID-19 Vaccine under way in Canada, many of those affected by PKD have questions. It is our goal to provide you with up-to-date information as it relates to this virus, the vaccine, and to help ease your mind during this challenging time.
The PKD Foundation of Canada was proud to present this complimentary webinar, “Polycystic Kidney Disease & the Pfizer-BioNTech COVID-19 Vaccine.” This webinar provided the opportunity to ask questions to one of the world’s leading nephrologists and PKD specialists, Dr. York Pei.
This webinar was live: Thursday January 21st- 7-9pm EST
Speaker: Dr. York Pei
About the Speaker:
Dr. Pei is a Professor of Medicine at the University of Toronto and a Staff Nephrologist at the Toronto General Hospital, University Health Network. He obtained his research training in Clinical Epidemiology at McMaster University and later on, in Human Molecular Genetics in Toronto.
The major theme of his research program is to identify genetic factors involved in the initiation or progression of common kidney diseases as potential targets for novel diagnostic tests and therapies. His research focuses on genetic, genomic and translational research of three common kidney disorders: Autosomal Dominant Polycystic Kidney Disease, IgA nephropathy and idiopathic nephrotic syndrome; and is supported by grants from the PKD Foundation of Canada, the Kidney Foundation of Canada, Physicians Incorporated Foundation and the Canadian Institutes of Health Research.
For more information on COVID-19 and the Pfizer-BioNTech COVID-19 Vaccine, visit the Government of Canada’s website here.